Holen Sie sich die Stockscreener-App
4.73
1.50%
0.07
Handel nachbörslich:
4.73
Schlusskurs vom Vortag:
$4.66
Offen:
$4.67
24-Stunden-Volumen:
297.32K
Relative Volume:
0.50
Marktkapitalisierung:
$1.47B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-2.5568
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
-7.80%
1M Leistung:
-13.21%
6M Leistung:
-46.31%
1J Leistung:
-64.30%
1-Tages-Spanne:
$4.62
$4.86
1-Wochen-Bereich:
$4.40
$5.14
52-Wochen-Spanne:
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.73 | 1.45B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
126.85 | 55.38B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.37 | 50.23B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.17B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.83 | 21.69B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
How Alvotech Equity Warrant stock reacts to job market data2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Is Alvotech Equity Warrant stock a contrarian buyQuarterly Profit Summary & Expert Approved Trade Ideas - ulpravda.ru
Will Alvotech (Z45) stock return to pre crash levelsMarket Growth Review & Advanced Swing Trade Entry Alerts - ulpravda.ru
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Is Alvotech Equity Warrant stock a dividend growth opportunityBreakout Watch & Accurate Technical Buy Alerts - ulpravda.ru
How Alvotech (Z45) stock correlates with oil marketsMarket Weekly Review & Daily Price Action Insights - ulpravda.ru
Why Alvotech stock is a must watch in 2025July 2025 Momentum & Weekly Momentum Stock Picks - ulpravda.ru
How Alvotech stock performs in weak economyTrade Risk Assessment & AI Forecast Swing Trade Picks - ulpravda.ru
Alvotech Corrects Disclosure on December 2025 Insider-Related Share Transactions - TipRanks
Correction: Transactions of Managers and Closely Associated Persons - The Manila Times
ATP Holdings ehf. Reports Share Transactions in Alvotech to CSSF - Quiver Quantitative
Why retail investors favor Alvotech stockMarket Profile Overview & Discover Your Financial Freedom Formula - ulpravda.ru
Is Alvotech stock near bottom after declineStraddle and Strangle Trades & Rapid Capital Growth - bollywoodhelpline.com
The Truth About Alvotech: Is This ‘Generic Giant’ Stock Your Next Power Move? - AD HOC NEWS
Alvotech Reports Major Insider-Related Share Purchases Filed in Luxembourg - TipRanks
Alvotech intros Simponi biosimilar in Europe - Drug Store News
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Transactions of Managers and Closely Associated Persons - The Manila Times
Viðskipti stjórnenda og tengdra aðila - GlobeNewswire Inc.
Alvotech (NASDAQ:ALVO) Shares Down 5.5%Time to Sell? - MarketBeat
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession - TipRanks
Startup Alvotech secures €100 mn term loan to fund 2026 execution - Beinsure
Alvotech names Lisa Graver as new CEO as founder steps back - Investing.com
Alvotech names Lisa Graver as new CEO as founder steps back By Investing.com - Investing.com Canada
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed - TipRanks
Alvotech Announces Leadership Transition: Róbert Wessman Remains Executive Chairman, Lisa Graver Appointed CEO - Quiver Quantitative
Alvotech announces planned CEO succession and leadership transition - The Manila Times
Alvotech Announces CEO Changes - MarketScreener
Alvotech (ALVO) Stock Analysis: Unveiling A Striking 352% Potential Upside - DirectorsTalk Interviews
Alvotech Secures $100 Million Term Loan Facility Led By GoldenTree - Pulse 2.0
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - FinancialContent
A Look At Alvotech (ALVO) Valuation After New US$100 Million Term Loan To Fund Biosimilar Pipeline - simplywall.st
Alvotech raises USD 100 million term loan to bolster biosimilar growth and 2026 launches - MSN
Icelandic biotech Alvotech secures to supercharge biosimilars pipeline and supply chain - Tech Funding News
Alvotech : Managers’ transactionsMTN ATP 19.12EN - MarketScreener
Alvotech : Managers' transactionsALVOTECH - MarketScreener
Alvotech (NasdaqGM:ALVO) Valuation Check After New $100 Million GoldenTree Term Loan for Biosimilar Growth - Yahoo Finance
The Truth About Alvotech: Why Everyone on Wall Street Suddenly Cares - AD HOC NEWS
Alvotech Stock Analysis and ForecastInstitutional Buying Trends & Free Superior Profit Margins - earlytimes.in
Alvotech secures USD 100M term loan - Medical Buyer
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches - TipRanks
Alvotech’s Volatile Ascent: Can A High?Beta Biosimilar Pure Play Keep Its Momentum? - AD HOC NEWS
Alvotech secures $100 million loan facility - Biostock
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment - EU-Startups
What analysts say about Alvotech Z45 stockEarnings Forecast Updates & Double Digit Returns - earlytimes.in
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in US - MSN
Alvotech Secures USD 100 Million Senior Term Loan to Enhance Liquidity and Support R&D Initiatives - Quiver Quantitative
Alvotech Secures Term Loan Facility of USD 100 Million - The Manila Times
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.41%
1.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):